Related Experiment Video
Updated: Oct 12, 2025

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis
Yoshitaka Kimura1,2, Daisuke Tsukui1, Hajime Kono1
1Department of Internal Medicine, Faculty of Medicine, Teikyo University of Medicine, Tokyo 173-8605, Japan.
Abstract:
Hyperuricemia is a common metabolic syndrome. Elevated uric acid levels are risk factors for gout, hypertension, and chronic kidney diseases. Furthermore, various epidemiological studies have also demonstrated an association between cardiovascular risks and hyperuricemia. In hyperuricemia, reactive oxygen species (ROS) are produced simultaneously with the formation of uric acid by xanthine oxidases. Intracellular uric acid has also been reported to promote the production of ROS. The ROS and the intracellular uric acid itself regulate several intracellular signaling pathways, and alterations in these pathways may result in the development of atherosclerotic lesions. In this review, we describe the effect of uric acid on various molecular signals and the potential mechanisms of atherosclerosis development in hyperuricemia. Furthermore, we discuss the efficacy of treatments for hyperuricemia to protect against the development of atherosclerosis.
Related Concept Videos
Atherosclerosis I: Introduction
Inflammation
Coronary Artery Disease II: Pathophysiology
Atherosclerosis III: Management
Peripheral Artery Disease I: Introduction
Coronary Artery Disease I: Introduction

